Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Boston MA, Brooklyn NY, Laurel MD, Chevy Chase MD,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase2, Phase3, Recruiting
Active & ResponsiveNew

[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma

for
Cholangiocarcinoma
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07673341

Phase2, Recruiting
Active & ResponsiveNew

Short-term Spinal Stimulation Effects in Cerebral Palsy

for
Cerebral Palsy
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 4 - 65

Code: NCT07826494

Recruiting
Active & ResponsiveNew

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

for
Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Brooklyn NY, Miami Lakes FL, Newmarket, North York,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07761117

Phase3, Recruiting
Active & ResponsiveNew

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 4 - 34

Code: NCT07216391

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

for
Metastatic Castration-Resistant Prostate Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07698535

Phase2, Recruiting
Active & ResponsiveNew

Within-Subject Comparison of Adipose Tissue Viability Following Liposuction

for
Liposuction
Location: Concord OH, Olympia WA
Sponsor: Apyx Medical

Sex: All

Age: 30 - 65

Code: NCT07820397

Recruiting
Active & ResponsiveNew

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

for
Metastatic Urothelial Carcinoma,
Location: Spokane WA, Los Angeles CA
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07815665

Phase2, Phase3, Recruiting
Active & Responsive

Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI

for
Spinal Cord Injuries
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21 - 65

Code: NCT06313515

Recruiting
Active & Responsive

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

for
Primary Central Nervous System Lymphoma
Location: New York NY, Burlington VT, Hershey PA,
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06175000

Phase2, Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: New Hyde Park NY, The Bronx NY, New York NY,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Weymouth MA, Boston MA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 60+

Code: NCT06377852

Phase3, Recruiting
Active & Responsive

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

for
Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 30

Code: NCT05105152

Phase1, Recruiting
Active & Responsive

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 0+

Code: NCT06145633

Phase2, Recruiting
Active & Responsive

Motor Recovery Through Plasticity-Inducing Cortical Stimulation

for
Stroke, Ischemic
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 22 - 70+

Code: NCT06506279

Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting
Active & Responsive

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

for
Solid Tumor, Adult, Colorectal Cancer,
Location: New York NY, Jacksonville FL, Tampa FL, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT04981119

Recruiting
Active & Responsive

Pilot Trial of the RUBI Program for Autistic Adults

for
Autism Spectrum Disorder, Behavior, Parenting
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 18+

Code: NCT06593613

Recruiting
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05788536

Phase1, Phase2, Recruiting
Active & Responsive

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

for
Central Nervous System Tumor, Diffuse Intrinsic Pontine Glioma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 1 - 26

Code: NCT04185038

Phase1, Recruiting

Popular cities in Washington State

SpokaneBellinghamSeattleKentEverettTacomaRenton